Zydus Cadila to launch an indigenously developed molecule
The Company has been working on a new molecule for diabetes.
Ahmedabad, March 19, 2013: Cadila Healthcare is expected to become one of the few Indian companies to be able to launch an indigenously developed molecule.
It is to be mentioned here that the company has been has been working on a new molecule for diabetes dyslipidemia, which is expected to be called 'Saroglitizar'. It is believed that the name has been derived from the Gujarati word ‘saro’ which means good.
The company has been working on the project since 2004 and it is believed that it will finish the project soon.